Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey

Genetics in Medicine

Volumn 14, Issue 1, 2012, Pages 69-75

  Palomaki, Glenn E ^a   Richards, C Sue ^b  

^a BROWN UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

analytic validity; external proficiency testing; Huntington disease; quality assurance

Indexed keywords

ARTICLE; DIAGNOSTIC TEST; GENETIC ANALYSIS; GOOD LABORATORY PRACTICE; HUMAN; HUNTINGTON CHOREA; LABORATORY TEST; MOLECULAR DIAGNOSIS; TRINUCLEOTIDE REPEAT; UNITED STATES; VALIDITY;

EID: 85027956019     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.0b013e3182310bb5     Document Type: Article

References (14)

1. Hayden M. Basal ganglia disorders. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, (eds). Emery and Rimoin's Principles and Practice of Medical Genetics. Churchill-Livingstone: New York, 1996:2203-2208.
2. GeneTests. http://www.ncbi.nlm.nih.gov/sites/GeneTests. Accessed 28 March 2011.
3. American College of Medical Genetics, Standards and Guidelines for Clinical Genetics Laboratories; 2006 Edition. Technical standards and guidelines for Huntington disease. http://www.acmg.net/Pages/ACMG-Activities/stds-2002/HD. htm. Accessed 28 March 2011.
4. Hudson KL. Genetic testing oversight. Science 2006;313:1853. (Pubitemid 44497970)
5. Hudson KL, Murphy JA, Kaufman DJ, Javitt GH, Katsanis SH, Scott J. Oversight of US genetic testing laboratories. Nat Biotechnol 2006;24:1083-1090. (Pubitemid 44359714)
6. Robins Wahlin TB. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease. Patient Educ Couns 2007;65: 279-287.
7. Potter NT, Spector EB, Prior TW. Technical standards and guidelines for Huntington disease testing. Genet Med 2004;6:61-65. (Pubitemid 38175981)
8. Ehrich M, Zoll S, Sur S, van den Boom D. A new method for accurate assessment of DNA quality after bisulfite treatment. Nucleic Acids Res 2007;35:e29.
9. Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res 2001;29:E65-E65.
10. United Kingdom National External Quality Assessment Scheme (NEQAS). http://www.ukneqas-molgen.org.uk/ukneqas/index/news.html. Accessed 28 March 2011.
11. European Molecular Genetics Quality Network (EMQN). http://www.emqn.org/ emqn/Schemes. Accessed 28 March 2011.
12. Royal College of Pathologists of Australasia (RCPA). http://www. rcpaqap.com. au/gendocs/uploadedfiles/InformationBooklet.pdf. Accessed 28 March 2011.
13. Best Practice European Molecular Genetics Quality Network (EMQN). Draft available at http://www.cmgs.org/BPGs/pdfs%20current%20bpgs/HD% 20BPG%20April%202010%20for%20consultation.pdf. Accessed 28 March 2011.
14. Kalman L, Johnson MA, Beck J, et al. Development of genomic reference materials for Huntington disease genetic testing. Genet Med 2007;9:719-723. (Pubitemid 350287158)